0001209191-19-018103.txt : 20190308
0001209191-19-018103.hdr.sgml : 20190308
20190308163021
ACCESSION NUMBER: 0001209191-19-018103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190220
FILED AS OF DATE: 20190308
DATE AS OF CHANGE: 20190308
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRYNJELSEN SEAN
CENTRAL INDEX KEY: 0001669976
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38738
FILM NUMBER: 19669494
MAIL ADDRESS:
STREET 1: C/O ETON PHARMACEUTICALS, INC.
STREET 2: 21925 W FIELD PKWY #235
CITY: DEER PARK
STATE: IL
ZIP: 60010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001710340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 371858472
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7208
BUSINESS PHONE: (847) 787-7361
MAIL ADDRESS:
STREET 1: 21925 W. FIELD PARKWAY
STREET 2: SUITE 235
CITY: DEER PARK
STATE: IL
ZIP: 60010-7208
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-20
0
0001710340
Eton Pharmaceuticals, Inc.
ETON
0001669976
BRYNJELSEN SEAN
21925 W FIELD PKWY #235
DEER PARK
IL
60010
1
1
0
0
President & CEO
Stock option (right to buy)
7.31
2019-02-20
4
A
0
250000
0.00
A
2029-02-19
Common Stock
250000
250000
D
The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2021.
/s/ W. Wilson Troutman, Attorney-in-fact
2019-03-08